摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氯-2-硝基苯甲酰氯 | 41994-44-9

中文名称
5-氯-2-硝基苯甲酰氯
中文别名
——
英文名称
5-chloro-2-nitrobenzoyl chloride
英文别名
2-nitro-5-chlorobenzoic acid chloride
5-氯-2-硝基苯甲酰氯化学式
CAS
41994-44-9
化学式
C7H3Cl2NO3
mdl
——
分子量
220.012
InChiKey
ZYUYCUXFKGUOSP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    62.9
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2916399090

SDS

SDS:7eeeb84ac7e90fd6da46cdeca7df873f
查看
Name: 5-Chloro-2-nitro-benzoylchloride Material Safety Data Sheet
Synonym:
CAS: 41994-44-9
Section 1 - Chemical Product MSDS Name:5-Chloro-2-nitro-benzoylchloride Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
41994-44-9 5-CHLORO-2-NITRO-BENZOYLCHLORIDE unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Contact with eyes may cause severe irritation, and possible eye burns.
Skin:
May cause severe irritation and possible burns.
Ingestion:
Not available.
Inhalation:
May cause severe irritation of the respiratory tract with sore throat, coughing, shortness of breath and delayed lung edema. Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids.
Skin:
Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Not available.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal.

Section 7 - HANDLING and STORAGE
Handling:
Not available.
Storage:
Corrosives area.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 41994-44-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149 approved full-facepiece airline respirator in the positive pressure mode with emergency escape provisions.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Not available.
Color: Not available.
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 0 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H3Cl2NO3
Molecular Weight: 220.01

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Not available.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 41994-44-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-CHLORO-2-NITRO-BENZOYLCHLORIDE - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, N.O.S.*
Hazard Class: 8
UN Number: 1759
Packing Group: II
IMO
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE SOLID, N.O.S.
Hazard Class: 8
UN Number: 1759
Packing group: II

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
WGK (Water Danger/Protection)
CAS# 41994-44-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 41994-44-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 41994-44-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    5-氯-2-硝基苯甲酰氯 在 10percent Pd/C 氢气 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 9.0h, 生成 2-amino-5-(dimethylamino)benzamide
    参考文献:
    名称:
    6-Alkylamino- and 2,3-Dihydro-3‘-methoxy-2-phenyl-4-quinazolinones and Related Compounds:  Their Synthesis, Cytotoxicity, and Inhibition of Tubulin Polymerization
    摘要:
    As part of our continuing search for potential anticancer candidates among 2-phenyl-4-quinolones and 2-phenyl-4-quinazolinones, two series of 6,7,2',3',4',5'-substituted 2-phenyl-4-quinazolinones and 6,2',3',4',5'-substituted 2,3-dihydro-2-phenyl-4-quinazolinones were synthesized and evaluated for cytotoxicity and as inhibitors of tubulin polymerization. In general, a good correlation was found between the two activities. Five of the 6-substituted heterocyclic 2-phenyl-4-quinozolinones (37-51) showed significant cytotoxicity against a panel of human tumor cell lines with EC50 values in the low micromolar to nanomolar concentration ranges. Compound 38 was the most potent of these compounds, as well as the most potent inhibitor of tubulin polymerization in this series. The activity of 38 was in the same range as those of the antimitotic natural products, colchicine, podophyllotoxin, and combretastatin A-4. Substituted 2-phenyl-4-quinazolinones and 2,3-dihydro-2-phenyl-4-quinazolinones also displayed highly selective cytotoxicity against the ovarian cancer 1A9 and P-gp resistant KB-VIN cell lines.
    DOI:
    10.1021/jm000151c
  • 作为产物:
    描述:
    参考文献:
    名称:
    作为潜在抗精神病药的新吡啶并二氮杂卓衍生物:合成和神经化学研究。
    摘要:
    发现一种新的,安全的,非典型的抗精神病药仍然是一项重要的挑战。为实现此目标,需要一系列N-甲基哌嗪子并吡啶并[2,3-b] [1,4]-和-[1,5]-和-pyrido [4,3-b] [1,4]-和-合成了[1,5]-苯并二氮杂s。多巴胺能(D1,D2),血清素能(5-HT2)和胆碱能(M)亲和力(通常在抗精神病药物的作用机理中得到体现)是使用它们各自的体外受体结合测定法确定的。每种化合物的所有亲和力均降低。发现最佳取代基在2或8位上以保持亲和力,而在5位上被酰基或烷基取代显着降低结合亲和力。吡啶并二氮杂卓衍生物,例如氯氮平,被发现对阿扑吗啡介导的刻板印象无活性或仅弱效。8-氯-6-(4-甲基-1-哌嗪基)-11H-吡啶酮在狗身上建立的原始且复杂的行为模型已成功用于区分不同种类的精神药物并区分典型和非典型的精神安定药[ 2,3-b] [1,4]苯二氮卓(9),8-甲基-6-(4-甲基-1-哌嗪基)-11H-吡啶基[2
    DOI:
    10.1021/jm00067a009
点击查看最新优质反应信息

文献信息

  • Structure–Activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors
    作者:Yuo-Ling Chou、David D Davey、Keith A Eagen、Brian D Griedel、Rushad Karanjawala、Gary B Phillips、Karna L Sacchi、Kenneth J Shaw、Shung C Wu、Dao Lentz、Amy M Liang、Lan Trinh、Michael M Morrissey、Monica J Kochanny
    DOI:10.1016/s0960-894x(02)00938-1
    日期:2003.2
    non-amidine factor Xa inhibitor with good selectivity against thrombin and trypsin. A series of modifications of the three aromatic groups of 1 was investigated. Substitution of chlorine or bromine for fluorine on the aniline ring led to the discovery of subnanomolar factor Xa inhibitors. Positions on the anthranilic acid ring that can accommodate further substitution were also identified.
    通过高通量筛选将化合物1鉴定为对凝血酶和胰蛋白酶具有良好选择性的新型有效非non因子Xa抑制剂。研究了1的三个芳族基团的一系列修饰。用氯或溴取代苯胺环上的氟导致发现亚纳摩尔因子Xa抑制剂。还确定了可以适应进一步取代的邻氨基苯甲酸环上的位置。
  • Novel approach to synthesis of substituted 3-aminoquinolines from nitroarenes and protected ethyl aminocrotonate
    作者:Robert Bujok、Andrzej Kwast、Piotr Cmoch、Zbigniew Wróbel
    DOI:10.1016/j.tet.2009.11.060
    日期:2010.1
    The addition of mono- and dianions of ethyl N-pivaloyl-3-aminocrotonate to substituted nitroarenes, followed by action of silylating or acylating agent, leads to 3-aminoquinoline carboxylic acid derivatives. Hydrolysis and decarboxylation of the latter, carried out efficiently under relatively mild conditions, afford 3-aminoquinolines diversely substituted in the benzo-fused ring.
    将N-新戊酰基-3-氨基巴豆酸乙酯的单和二价阴离子加到取代的硝基芳烃上,然后甲硅烷基化或酰化剂作用,产生3-氨基喹啉羧酸衍生物。在相对温和的条件下有效地进行后者的水解和脱羧,得到在苯并稠合的环中被不同取代的3-氨基喹啉。
  • METHOD FOR PRODUCING DICARBOXYLIC ACID COMPOUND
    申请人:DAIICHI SANKYO COMPANY, LIMITED
    公开号:US20180148424A1
    公开(公告)日:2018-05-31
    It is an object of the present invention to provide an excellent method for producing an excellent therapeutic agent. The solution of the present invention is as shown in the following scheme: wherein R 1 represents a C1-C6 alkyl group, R 2 represents a C1-C6 alkyl group, and R 3 represents a C1-C6 alkyl group.
    本发明的目的是提供一种优秀的生产优秀治疗剂的方法。 本发明的解决方案如下图所示: 其中R1代表C1-C6烷基,R2代表C1-C6烷基,R3代表C1-C6烷基。
  • Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells
    作者:Brian D. Palmer、William R. Wilson、Stephen Cliffe、William A. Denny
    DOI:10.1021/jm00095a018
    日期:1992.8
    Nitroaniline mustards have potential as hypoxia-selective cytotoxic agents, with reductive metabolism activating the nitrogen mustard by converting the electron-withdrawing nitro group to an electron-donating hydroxylamine or amine. However, the parent compounds have poor aqueous solubility, and their potencies are limited by low reduction potentials (E1/2 ca. -600 mV versus the normal hydrogen electrode)
    硝基苯胺芥子作为低氧选择性细胞毒剂具有潜力,其还原性代谢通过将吸电子硝基转化为供电子羟胺或胺来激活氮芥。然而,母体化合物的水溶性差,并且它们的效能受到低还原电位(相对于正常氢电极的E1 / 2约-600mV)和相应的缓慢的硝基还原速率的限制。为了解决这些局限性,制备了一系列通过吸电子羧酰胺基团连接的带有亲水性侧链的4-硝基苯胺芥菜,并评估了其对中国仓鼠细胞系的低氧选择性细胞毒性。N-[(N,N-二甲基氨基)乙基]羧酰胺衍生物具有优异的水溶性和改善的细胞毒性,但是它们的还原潜力虽然比非羧酰胺化合物高,但仍然很低,并且观察到的对缺氧细胞的选择性很小。还制备了一系列的2,4-二硝基苯胺芥末羧酰胺。这些化合物的还原电位在所需范围内(通过循环伏安法测得的E1 / 2约为-450 mV),并且对缺氧的毒性比需氧的UV4细胞高。选择性最高的化合物是5- [N,N-双(2-氯乙基)氨基] -2,4-二硝基苯甲酰胺(20,SN
  • Covalent Occlusion of the RORγt Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site
    作者:Femke A. Meijer、Maxime C. M. van den Oetelaar、Richard G. Doveston、Ella N. R. Sampers、Luc Brunsveld
    DOI:10.1021/acsmedchemlett.1c00029
    日期:2021.4.8
    autoimmune diseases, and inhibition of RORγt with small molecules thus holds great potential as a therapeutic strategy. RORγt has a unique allosteric ligand binding site in the ligand binding domain, which is distinct from the canonical, orthosteric binding site. Allosteric modulation of RORγt shows high potential, but the targeted discovery of novel allosteric ligands is highly challenging via currently
    核受体RORγt是T辅助细胞17(Th17)细胞分化和增殖以及促炎性细胞因子(如IL-17a)产生的关键正调控因子。该途径的失调可导致各种自身免疫性疾病的发展,因此用小分子抑制RORγt具有作为治疗策略的巨大潜力。RORγt在配体结合结构域中具有独特的变构配体结合位点,其不同于典型的正构结合位点。RORγt的变构调节显示出很高的潜力,但是通过目前可用的方法,靶向发现新的变构配体具有很高的挑战性。在此,我们介绍RORγt的共价正构化学探针,该探针封闭正构,正构配体的结合,但仍允许变构配体结合。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐